Ovarian Cancer Canada

Western Regional Blog – BC, YK, AB, NWT and Nunavut

Helping You with Cancer Care Wherever You Are

Be part of a unique online program that brings integrative cancer care to the comfort of your home. InspireHealth ONLINE is an integrative cancer care program that can be accessed … Continue reading

October 25, 2013

A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer

“Vintafolide plus PLD is the first combination to demonstrate an improvement over standard therapy in a randomized trial of patients with platinum-resistant ovarian cancer…”  R. Wendel Naumann, Robert L. Coleman, … Continue reading

October 16, 2013

Patient Selection and Targeted Treatment in the Management of Platinum-Resistant Ovarian Cancer

“…there is an increasing need for the identification of response predictive biomarkers. Selecting the right patients through biomarker screening will help tailor therapy to patients and decrease superfluous treatment to … Continue reading

October 16, 2013

Emotions and Social Relationships for Breast and Gynecologic Patients: A Qualitative Study of Coping with Recurrence

In contrast to the large literature on patients’ coping with an initial diagnosis of cancer, there have been few quantitative or qualitative studies of patients coping with recurrence.  Lisa M. … Continue reading

October 16, 2013

Ovarian Cancer Action (UK) 5th Anniversary Symposium

  On the 4th July of this year, eminent scientists, ovarian cancer researchers, gynaecological oncologists and other healthcare staff, partners and funders joined us at the Caledonian Club (SW1 London) … Continue reading

October 16, 2013

TRINOVA-1 Signals New Direction in Ovarian Cancer

“Adding the investigational peptibody trebananib to weekly paclitaxel prolongs the time to disease progression or death in women with recurrent, advanced ovarian cancer, the phase III TRINOVA-1 trial has shown.”  … Continue reading

October 16, 2013

ICON6 Ovarian Cancer Results May Resurrect Cediranib

“These are important results for women with recurrence ovarian cancer,” Prof. Cornelis van de Velde, European Cancer Organization president, commented in a statement. “Once the disease has recurred, there are … Continue reading

October 16, 2013

J&J’s Doxil Shortage to Last until at Least End of 2014 (US)

“Sun Pharma’s generic will be only version available.”  October 7, 2013 | By Eric Palmer http://www.fiercepharma.com/story/jjs-doxil-shortage-last-until-least-end-2014/2013-10-07 The saga of the shortage of ovarian cancer drug Doxil has hit a new … Continue reading

October 16, 2013

The Role of PARP Inhibitors in the Treatment of Gynecologic Malignancies

“The focus of this review will be on pre-clinical data, current clinical trials, and the future of PARP inhibitors in the treatment of ovarian, endometrial, and cervical cancer.”  Raquel E. … Continue reading

October 16, 2013

Complementary and Alternative Therapies


Research in BC

The Injustices of Ovarian Cancer

Ovarian Cancer Canada